{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:50:38Z","timestamp":1782924638851,"version":"3.54.5"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006924","name":"International OCD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP #38077"],"award-info":[{"award-number":["MOP #38077"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003248","name":"Ontario Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pnpbp.2025.111428","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:08:24Z","timestamp":1749654504000},"page":"111428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dopamine D3 receptor gene is associated with obsessive-compulsive disorder and antidepressant response"],"prefix":"10.1016","volume":"140","author":[{"given":"Gwyneth","family":"Zai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0005","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","article-title":"Pramipexole in psychiatry: a systemic review of the literature","volume":"68","author":"Aiken","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41398-020-0804-z","article-title":"Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study","volume":"10","author":"Alemany-Navarro","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.biopsych.2007.06.020","article-title":"Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder","volume":"63","author":"Alonso","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<669::AID-AJMG17>3.0.CO;2-N","article-title":"Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores","volume":"88","author":"Alsobrook","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.mp.4001003","article-title":"Characterization, mutation detection, and association analysis of alternative promoters and 5\u2019 UTRs of the human dopamine D3 receptor gene in schizophrenia","volume":"7","author":"Anney","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0030","series-title":"A Comprehensive Handbook of Child and Adolescent Obsessive-Compulsive Disorder","article-title":"Genetics of obsessive-compulsive disorder: Evidence from pediatric and adult studies","author":"Arnold","year":"2007"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.651196","article-title":"Are there familial patterns of symptom dimensions in obsessive-compulsive disorder?","volume":"12","author":"Balachander","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1741-7007-3-4","article-title":"Sequential super-stereotypy of an instinctive fixed action pattern in hyperdopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette\u2019s","volume":"3","author":"Berridge","year":"2005","journal-title":"BMC Biol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00041444-199800830-00005","article-title":"Investigation of dopamine system genes in obsessive-compulsive disorder","volume":"8","author":"Billett","year":"1998","journal-title":"Psychiatr. Genet."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v65n0418","article-title":"Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial","volume":"65","author":"Bystritsky","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"6\u20137","key":"10.1016\/j.pnpbp.2025.111428_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.euroneuro.2006.08.001","article-title":"Association study between the dopamine receptor D(4) gene and obsessive-compulsive disorder","volume":"17","author":"Camarena","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0065","article-title":"A coordinate-based meta-analysis of grey matter volume differences between adults with obsessive-compulsive disorder (OCD) and healthy controls","volume":"345","author":"Casale","year":"2024","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ajmg.1320540312","article-title":"Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations","volume":"54","author":"Catalano","year":"1994","journal-title":"Am. J. Med. Genet."},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2025.111428_bb0075","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S1353-8020(09)70847-8","article-title":"Impulse control disorders in Parkinson\u2019s disease: definition, epidemiology, risk factors, neurobiology and management","volume":"15","author":"Ceravolo","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/biom12020243","article-title":"Neurobiological and pharmacological prespectives of D3 receptors in Parkinson\u2019s disease","volume":"12","author":"Chagraoui","year":"2022","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.pnpbp.2025.111428_bb0090","first-page":"S11","article-title":"The role of dopamine in obsessive-compulisve disorder: preclinical and clinical evidence","volume":"65","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.euroneuro.2005.12.001","article-title":"Association between the dopamine D(2) receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males","volume":"16","author":"Denys","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111428_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"18","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cpr.2004.08.004","article-title":"A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder","volume":"24","author":"Eddy","year":"2004","journal-title":"Clin. Psychol. Rev."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/mp.2009.95","article-title":"Insights into pathophysiology of punding reveal possible treatment strategies","volume":"15","author":"Fasano","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.psychres.2008.06.008","article-title":"Tourette\u2019s syndrome, trichotillomania, and obsessive-compulsive disorder: how closely are they related?","volume":"170","author":"Ferr\u00e4o","year":"2009","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.yic.0000215083.57801.11","article-title":"Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials","volume":"21","author":"Fineberg","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0135","series-title":"Structured Clinical Interview for DSM-IV axis I Disorders-Research Version (SCID-I\/P, Version 2.0, February, Final Version)","author":"First","year":"1996"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111428_bb0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/11591790-000000000-00000","article-title":"Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments","volume":"71","author":"Fontenelle","year":"2011","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111428_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-3223(94)90636-X","article-title":"Punding on levodopa","volume":"36","author":"Friedman","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"20","key":"10.1016\/j.pnpbp.2025.111428_bb0150","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.191353298","article-title":"Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter","volume":"98","author":"Gainetdinov","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0160","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jaac.2010.04.009","article-title":"The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery","volume":"49","author":"Grados","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0170","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hbm.20392","article-title":"Brain region binding of the D(2\/3) agonist [(11)C]-(+)-PHNO and the D(2\/3) antagonist [(11)C] raclopride in healthy humans","volume":"29","author":"Graff-Guerrero","year":"2007","journal-title":"Human Brain Mapp."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/377003","article-title":"Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder","volume":"73","author":"Hall","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/15622970701245003","article-title":"Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD)","volume":"9","author":"Hemmings","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111428_bb0190","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/mp.2017.154","article-title":"Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis","volume":"23","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3000","article-title":"Obsessive-compulsive disorder: etiology, neuropathology, and cognitive dysfunction","volume":"13","author":"Jalal","year":"2023","journal-title":"Brain Behav."},{"issue":"28","key":"10.1016\/j.pnpbp.2025.111428_bb0200","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1073\/pnas.0508189103","article-title":"A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor","volume":"103","author":"Jeanneteau","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0205","series-title":"Obsessive-Compulsive Disorders: Theory and Management","author":"Jenike","year":"1986"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111428_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00124-0","article-title":"Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders","volume":"119","author":"Joyce","year":"2003","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0215","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ajmg.b.30930","article-title":"The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD)","volume":"150","author":"Katerberg","year":"2009","journal-title":"Am. J. Med. Genet. (Neuropsychiatr. Genet.)"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2009.05.084","article-title":"DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease","volume":"461","author":"Keeling","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1283572","article-title":"The shared genetic risk factors between Tourette syndrome and obsessive-compulsive disorders","volume":"14","author":"Khoodoruth","year":"2023","journal-title":"Front. Neurol."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2025.111428_bb0235","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2010.08.026","article-title":"Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats","volume":"647","author":"Kitaichi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.psc.2006.02.007","article-title":"Animal models of obsessive-compulsive disorders: rationale to understanding psychobiology and pharmacology","volume":"29","author":"Korff","year":"2006","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0250","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2025.111428_bb0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M","article-title":"Implementing a unified approach to family-based tests of association","volume":"19","author":"Laird","year":"2000","journal-title":"Genet. Epidemiol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0260","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1086\/344696","article-title":"Power and design considerations for a general class of family-based association tests: quantitative traits","volume":"71","author":"Lange","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0265","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.10170","article-title":"Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats","volume":"47","author":"Le Foll","year":"2003","journal-title":"Synapse (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00001756-200502080-00022","article-title":"A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning","volume":"16","author":"Le Foll","year":"2005","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0275","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuropharm.2005.04.022","article-title":"The dopamine D3 receptor and drug dependence: effects on reward or beyond?","volume":"49","author":"Le Foll","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.10001","article-title":"Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome","volume":"116B","author":"Leckman","year":"2003","journal-title":"Am. J. Med. Genet."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111428_bb0285","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","article-title":"Association of DRD3 and GRIN2B with impulse control and related behaviours in Parkinson\u2019s disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11065-019-09402-x","article-title":"A systematic meta-review of impulsivity and compulsivity in addictive behaviors","volume":"29","author":"Lee","year":"2019","journal-title":"Neuropsychol. Rev."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajmg.b.30308","article-title":"Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive-compulsive personality disorder in patients with major depression","volume":"141B","author":"Light","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0305","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.psychres.2010.08.030","article-title":"Association analysis of serotonin and catecholamine system candidate genes in obsessive-compulsive disorder in the Chinese population","volume":"188","author":"Liu","year":"2011","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111428_bb0310","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00228-009-0658-z","article-title":"Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson\u2019s disease patients","volume":"65","author":"Liu","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0315","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1006\/bbrc.1996.1296","article-title":"Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system","volume":"225","author":"Lundstrom","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.pnpbp.2025.111428_bb0320","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1017\/S0033291721001744","article-title":"Genetics of obsessive-compulsive disorder","volume":"51","author":"Mahjani","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajmg.b.30370","article-title":"Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding","volume":"144B","author":"Mathews","year":"2007","journal-title":"Am. J. Med. Genet."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0335","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0340","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.parkreldis.2007.04.004","article-title":"Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy","volume":"13","author":"McKeon","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2023.12.010","article-title":"Deep brain stimulation for obsessive-compulsive disorder: optimal stimulation sites","volume":"96","author":"Meyer","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0350","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/sj.mp.4001617","article-title":"Obsessive-compulsive disorder phenotypes: implications for genetic studies","volume":"10","author":"Miguel","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0355","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.10034","article-title":"Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder","volume":"116","author":"Millet","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0360","first-page":"461","article-title":"DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder","volume":"1","author":"Nicolini","year":"1996","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.psychres.2008.10.011","article-title":"Overview of genetics and obsessive-compulsive disorder","volume":"170","author":"Nicolini","year":"2009","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111428_bb0370","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145702002900","article-title":"Treatment non-response in OCD: methodological issues and operational definitions","volume":"5","author":"Pallanti","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0380","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","article-title":"Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist","volume":"400","author":"Pilla","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0385","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-3223(89)90022-X","article-title":"Animal models of compulsive behaviour","volume":"26","author":"Pitman","year":"1989","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111428_bb0390","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/neuros\/nyaa249","article-title":"A systematic review of deep brain stimulation targets for obsessive compulsive disorder","volume":"87","author":"Raviv","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0395","first-page":"42","article-title":"Anxiety disorders in Parkinson\u2019s disease","volume":"96","author":"Richard","year":"2005","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0400","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.154.2.147","article-title":"The Gilles de la Tourette syndrome: the current status","volume":"154","author":"Robertson","year":"1989","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111428_bb0405","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S1516-44462010000300023","article-title":"Positive association between MET allele (BDNF Val66Met polymorphism) and obsessive-compulsive disorder","volume":"32","author":"da Rocha","year":"2010","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054108","article-title":"The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement","volume":"8","author":"Savitz","year":"2013","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111428_bb0425","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2007.01.009","article-title":"Risk factors for pathologic gambling and other compulsions among Parkinson\u2019s disease patients taking dopamine agonists","volume":"14","author":"Singh","year":"2007","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(99)00921-0","article-title":"A cluster of single nucleotide polymorphisms in the 5\u2032-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia","volume":"279","author":"Sivagnanasundaram","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euroneuro.2006.07.002","article-title":"Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials","volume":"17","author":"Skapinakis","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6289","key":"10.1016\/j.pnpbp.2025.111428_bb0440","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature (London)"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0445","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2004.06.011","article-title":"Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population","volume":"73","author":"Staddon","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0450","article-title":"Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci","author":"Strom","year":"2024","journal-title":"medRxiv [preprint] mar 13:2024.03.13.24304161"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0460","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pnpbp.2012.10.023","article-title":"DRD4 gene and obsessive compulsive disorder: do symptom dimensions have specific genetic correlates?","volume":"41","author":"Taj","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111428_bb0465","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/mp.2012.76","article-title":"Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0470","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","article-title":"Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0475","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviours in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111428_bb0480","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00702-008-0051-6","article-title":"Transmission disequilibrium studies in early onset of obsessive-compulsive disorder for polymorphisms in genes of the dopaminergic system","volume":"115","author":"Walitza","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111428_bb0485","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/sj.npp.1301394","article-title":"A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder","volume":"32","author":"Wendland","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0490","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pscychresns.2004.07.001","article-title":"A meta-analysis of functional neuroimaging in obsessive-compulsive disorder","volume":"132","author":"Whiteside","year":"2004","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111428_bb0495","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3171\/2023.4.JNS221824","article-title":"Use of differential stimulation of the nucleus accumbens and anterior limb of the internal capsule to improve outcomes of obsessive-compulsive disorder","volume":"139","author":"Xiong","year":"2023","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111428_bb0500","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00406-023-01594-x","article-title":"A multimodal meta-analysis of regional functional and structural brain abnormalities in obsessive-compulsive disorder","volume":"274","author":"Yang","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0505","series-title":"Obsessive-Compulsive Disorder Spectrum: Pathogenesis, Diagnosis, and Treatment","author":"Yaryura-Tobias","year":"1997"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111428_bb0510","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.pnpbp.2010.07.019","article-title":"Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs","volume":"34","author":"Zai","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111428_bb0515","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/7854_2020_205","article-title":"Pharmacogeneitcs of obsessive-compulsive disorder: an evidence-update","volume":"49","author":"Zai","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111428_bb0525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YPG.0000000000000230","article-title":"New insights and perspectives on the genetics of obsessive-compulsive disorder","volume":"29","author":"Zai","year":"2019","journal-title":"Psychiatr. Genet."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111428_bb0530","doi-asserted-by":"crossref","first-page":"187","DOI":"10.32598\/bcn.12.2.941.7","article-title":"Obsessive-compulsive disorder interactome profile analysis: a perspective from molecular mechanism","volume":"12","author":"Zamanian-Azodi","year":"2021","journal-title":"Basic Clin. Neurosci."},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2025.111428_bb0535","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000114040","article-title":"Is dopamine agonist therapy associated with developing pathological gambling in Parkinson\u2019s disease patients?","volume":"59","author":"Zand","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.pnpbp.2025.111428_bb0540","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpsychires.2019.01.014","article-title":"Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: a network meta-analysis","volume":"111","author":"Zhou","year":"2019","journal-title":"J. Psychiatr. Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:15:16Z","timestamp":1752675316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":102,"alternative-id":["S0278584625001824"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111428","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D3 receptor gene is associated with obsessive-compulsive disorder and antidepressant response","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111428"}}